Bristol Myers, Takeda to pool data in AI drug effort

Bristol Myers Squibb, Takeda Pharmaceuticals and Astex Pharmaceuticals are coming together to share proprietary data for training an artificial intelligence model to assist drug discovery and development.

- SNEHA SK

The companies are joining a consortium that includes AbbVie and Johnson & Johnson, and will contribute data from several thousand experimentally determined protein-small molecule structures to train an AI model called OpenFold3, life sciences company Apheris said yesterday.

The initiative is based on a federated data sharing model, which enables collaboration without exposing sensitive data.